138 related articles for article (PubMed ID: 26337302)
1. Exocrine Pancreatic carcinoma in Tunisia: A retrospective study about 158 cases.
El Guesmi S; Ben Nasr S; Afrit M; Labidi S; Boussen H
Tunis Med; 2015 Feb; 93(2):73-5. PubMed ID: 26337302
[TBL] [Abstract][Full Text] [Related]
2. The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer.
Gobbi PG; Bergonzi M; Comelli M; Villano L; Pozzoli D; Vanoli A; Dionigi P
Cancer Epidemiol; 2013 Apr; 37(2):186-90. PubMed ID: 23369450
[TBL] [Abstract][Full Text] [Related]
3. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
[TBL] [Abstract][Full Text] [Related]
4. The incidence and outcomes of pancreatectomy in patients with metastatic pancreatic adenocarcinoma.
McKenzie S; Mailey B; Artinyan A; Kim J; Ellenhorn JD
JOP; 2010 Jul; 11(4):341-7. PubMed ID: 20601808
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neoplasm in 2011: an update.
Saif MW
JOP; 2011 Jul; 12(4):316-21. PubMed ID: 21737886
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Papadoniou N; Kosmas C; Gennatas K; Polyzos A; Mouratidou D; Skopelitis E; Tzivras M; Sougioultzis S; Papastratis G; Karatzas G; Papalambros E; Tsavaris N
Anticancer Res; 2008; 28(1B):543-9. PubMed ID: 18383900
[TBL] [Abstract][Full Text] [Related]
8. [Primary digestive tract lymphoma in central region of Tunisia: anatomoclinical study and therapeutic results about 153 cases].
Landolsi A; Chabchoub I; Limem S; Gharbi O; Chaafai R; Hochlef M; Fatma LB; Trimech M; Krifa A; Ajmi S; Mokni M; Hadj Hmida MB; Ahmed SB
Bull Cancer; 2010 Apr; 97(4):435-43. PubMed ID: 20395189
[TBL] [Abstract][Full Text] [Related]
9. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
11. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
12. [Pancreatic carcinoma].
Böhmig M; Rosewicz S
Z Gastroenterol; 2004 Mar; 42(3):261-8. PubMed ID: 15022114
[TBL] [Abstract][Full Text] [Related]
13. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
14. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW; Haller DG; Rosato EF; Plastaras JP
JOP; 2011 Sep; 12(5):438-44. PubMed ID: 21904068
[TBL] [Abstract][Full Text] [Related]
15. Differences in survival by histologic type of pancreatic cancer.
Fesinmeyer MD; Austin MA; Li CI; De Roos AJ; Bowen DJ
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1766-73. PubMed ID: 16030115
[TBL] [Abstract][Full Text] [Related]
16. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
17. [Pancreatic adenocarcinoma: therapeutical update].
Khosravi Shahi P; Díaz Muñoz de la Espada VM
An Med Interna; 2005 Aug; 22(8):390-4. PubMed ID: 16351494
[TBL] [Abstract][Full Text] [Related]
18. [Up-to-date diagnosis and treatment of advanced pancreatic cancer].
Stieler JM; Oettle H
Dtsch Med Wochenschr; 2005 Sep; 130(38):2146-8. PubMed ID: 16172956
[TBL] [Abstract][Full Text] [Related]
19. [Current standards in the treatment of pancreatic cancer].
Pelzer U; Riess H
Dtsch Med Wochenschr; 2015 Dec; 140(24):1813-6. PubMed ID: 26625229
[TBL] [Abstract][Full Text] [Related]
20. [Management of localized, locally advanced and metastatic pancreatic adenocarcinoma].
Delpero JR; Turrini O; Raoul JL
Rev Prat; 2015 Mar; 65(3):382-9. PubMed ID: 26016202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
